SEPTISOL Drug Patent Profile
✉ Email this page to a colleague
When do Septisol patents expire, and when can generic versions of Septisol launch?
Septisol is a drug marketed by Vestal Labs and is included in two NDAs.
The generic ingredient in SEPTISOL is hexachlorophene. There are seven drug master file entries for this compound. Additional details are available on the hexachlorophene profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SEPTISOL?
- What are the global sales for SEPTISOL?
- What is Average Wholesale Price for SEPTISOL?
Summary for SEPTISOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 3,863 |
| DailyMed Link: | SEPTISOL at DailyMed |
US Patents and Regulatory Information for SEPTISOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vestal Labs | SEPTISOL | hexachlorophene | AEROSOL;TOPICAL | 017424-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Vestal Labs | SEPTISOL | hexachlorophene | SOLUTION;TOPICAL | 017423-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
